165 related articles for article (PubMed ID: 19917373)
1. Monitoring of C0 and C2 blood concentrations of cyclosporine on the Roche Hitachi 902 analyzer.
Yargui L; Berhoune A
Transplant Proc; 2009 Nov; 41(9):3713-9. PubMed ID: 19917373
[TBL] [Abstract][Full Text] [Related]
2. [The EMIT Tacrolimus assay: development of application protocol for Roche Hitachi 902 analyzer].
Yargui L; Berhoune A
Ann Biol Clin (Paris); 2008; 66(6):657-64. PubMed ID: 19091665
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
[TBL] [Abstract][Full Text] [Related]
5. Automated monitoring of C2 and C0 blood levels of mycophenolic acid and cyclosporine on the Abbott Architect c8000.
Boer K; Brehmer-Streck S; Deufel T; Schmidt D; Kiehntopf M
Clin Biochem; 2007 Oct; 40(15):1163-7. PubMed ID: 17689516
[TBL] [Abstract][Full Text] [Related]
6. The V-twin system (Dade Behring Laboratories): a useful tool for immunosuppressive drug monitoring.
Elaerts S; Olejnik Y; Bonardet A; Garrigue V; Mourad G; Cristol JP; Dupuy AM
Transplant Proc; 2005; 37(1):167-71. PubMed ID: 15808583
[TBL] [Abstract][Full Text] [Related]
7. Preliminary evaluation of a new chemiluminescence assay (Liaison Cyclosporine; DiaSorin Laboratories) allowing both C0 and C2 cyclosporine levels determination: comparison with RIA method.
Olejnik Y; Elaerts S; Bonardet A; Chong G; Mourad G; Cristol JP; Dupuy AM
Transplant Proc; 2005; 37(1):172-4. PubMed ID: 15808584
[TBL] [Abstract][Full Text] [Related]
8. The EMIT Cyclosporine Assay: development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers.
Dias VC; Legatt DF; Yatscoff RW
Clin Biochem; 1997 Mar; 30(2):155-62. PubMed ID: 9127698
[TBL] [Abstract][Full Text] [Related]
9. A survey to determine the blood concentration of cyclosporine 2 hours postdose in stable renal transplant patients.
Jorga A; Holt DW; Yaqoob M; Whittaker C; Johnston A
Transplant Proc; 2004 Dec; 36(10):3239-41. PubMed ID: 15686737
[TBL] [Abstract][Full Text] [Related]
10. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
LeGatt DF; Shalapay CE; Cheng SB
Clin Biochem; 2004 Nov; 37(11):1022-30. PubMed ID: 15498532
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation.
Cattaneo D; Zenoni S; Murgia S; Merlini S; Baldelli S; Perico N; Gotti E; Ottomano C; Crippa A; Remuzzi G
Clin Chim Acta; 2005 May; 355(1-2):153-64. PubMed ID: 15820490
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the new heterogeneous ACMIA immunoassay for the determination of whole-blood cyclosporine concentrations in bone marrow, kidney, heart, and liver transplant recipients.
Huet E; Morand K; Blanchet B; Astier A; Hulin A
Transplant Proc; 2004 Jun; 36(5):1317-20. PubMed ID: 15251322
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
Loichot C; Bentue-Ferrer D; Bernard N; Bonardet A; Boulieu R; Kergueris MF; Paintaud G; Peytavin G; Simon N; Marquet P;
Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
[TBL] [Abstract][Full Text] [Related]
14. Correlation of C0 and C2 levels with cyclosporine side effects in kidney transplantation.
Rodrigo E; Ruiz JC; Angeles de Cos M; Ruiz J; Gago M; Piñera C; Sánchez B; González-Cotorruelo J; Gómez-Alamillo C; Arias M
Transplant Proc; 2009; 41(6):2328-31. PubMed ID: 19715910
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target.
Higgins RM; Kanji H; Hernon M; Harrison P; Lam FT; Kashi SH
Transpl Int; 2005 Jul; 18(7):806-10. PubMed ID: 15948859
[TBL] [Abstract][Full Text] [Related]
17. C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
Midtvedt K; Fauchald P; Bergan S; Høieggen A; Hallan S; Svarstad E; Bergrem H; Eriksen BO; Pfeffer PF; Dalen I; Leivestad T
Transplantation; 2003 Oct; 76(8):1236-8. PubMed ID: 14578761
[TBL] [Abstract][Full Text] [Related]
18. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I
Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128
[TBL] [Abstract][Full Text] [Related]
19. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
20. Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods.
Soylu A; Kavukçu S; Türkmen MA; Kasap B; Soylu A; Bora S; Gülay H
Transplant Proc; 2006 Jun; 38(5):1286-9. PubMed ID: 16797283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]